StrategyDiscovery layer
Why LegUpRx Turns Wellness Clients Into Recurring Revenue for Agencies
LegUpRx hands agencies a telehealth product they can brand and resell without a medical license, and the margin sits above LegUpRx's wholesale medication cost.
By InnovaAI ResearchPublished
Why does it matter for agencies?
Leverage
42/100Risk
68/100LegUpRx hands agencies a telehealth product they can brand and resell without a medical license, and the margin sits above LegUpRx's wholesale medication cost. The catch is that LegUpRx keeps clinical liability and a backend brand presence, so the agency's recurring revenue depends on a licensed network it does not control. For agencies already holding B2C wellness relationships, that trade is worth modeling before pitching.
More on LegUpRx
- ConceptLegUpRx Margin Stack
- Evaluation RuleLegUpRx Rule: Only Resell It to Clients Who Already Own the Patient Relationship
- Decision FrameworkLegUpRx: Buy vs Skip (Agency White-Label Telehealth Decision)
- Failure PatternWhy Agencies Fail With LegUpRx in Wellness Verticals: The Margin Mirage
- Implementation BlueprintLegUpRx White-Label Telehealth Launch (7-10 days)
- Operating ProcedureLegUpRx White-Label Storefront Launch (Onboarding)